FDA — authorised 16 May 2018
- Marketing authorisation holder: US WORLDMEDS LLC
- Status: approved
FDA authorised Lucemyra on 16 May 2018
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 16 May 2018.
US WORLDMEDS LLC holds the US marketing authorisation.